Clarivate reported total revenues of $593.7 million for the first quarter of 2025, a decrease from $621.2 million in the prior year. The company experienced a net loss of $103.9 million, or $0.15 per diluted share, and generated $171.2 million in operating cash flow. Despite the revenue decline, organic recurring revenues increased by 0.6%, driven by higher IP patent renewal volumes.
Total revenues for Q1 2025 decreased by 4.4% to $593.7 million, primarily due to inorganic divestitures and foreign currency impacts.
The company reported a net loss of $103.9 million in Q1 2025, compared to a net loss of $75.0 million in Q1 2024.
Adjusted EBITDA for Q1 2025 was $233.2 million, a slight decrease from $236.3 million in the prior year.
Clarivate generated strong operating cash flow of $171.2 million and free cash flow of $110.3 million, and repurchased $50.0 million of ordinary shares.
Clarivate reaffirmed its full year 2025 outlook, expecting continued organic growth and strong financial performance, with specific ranges provided for key metrics.
Analyze how earnings announcements historically affect stock price performance